相似文献
1
The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome.
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S155-60. doi: 10.1016/j.ijrobp.2009.08.074.
2
Reporting Standards for Complication Studies of Radiation Therapy for Pediatric Cancer: Lessons From PENTEC.
Int J Radiat Oncol Biol Phys. 2024 Jun 1;119(2):697-707. doi: 10.1016/j.ijrobp.2024.02.018.
3
Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature.
Eur Urol. 2012 Jan;61(1):112-27. doi: 10.1016/j.eururo.2011.09.027. Epub 2011 Oct 6.
4
Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.
Eur Urol. 2019 Mar;75(3):464-476. doi: 10.1016/j.eururo.2018.12.003. Epub 2018 Dec 17.
5
Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
Acta Oncol. 2010 Oct;49(7):1040-4. doi: 10.3109/0284186X.2010.509736.
6
Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients.
Clin Oncol (R Coll Radiol). 2019 Mar;31(3):199-207. doi: 10.1016/j.clon.2019.01.002. Epub 2019 Jan 19.
7
A Systematic Post-QUANTEC Review of Tolerance Doses for Late Toxicity After Prostate Cancer Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1514-1532. doi: 10.1016/j.ijrobp.2018.08.015. Epub 2018 Aug 17.
8
Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma.
Cochrane Database Syst Rev. 2019 Aug 5;8(8):CD013047. doi: 10.1002/14651858.CD013047.pub2.
9
A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity.
Radiother Oncol. 2010 Feb;94(2):241-7. doi: 10.1016/j.radonc.2009.12.019. Epub 2010 Jan 22.
10
Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.
Cochrane Database Syst Rev. 2018 Jul 9;7(7):CD011492. doi: 10.1002/14651858.CD011492.pub2.
引用本文的文献
1
Artificial intelligence for response prediction and personalisation in radiation oncology.
Strahlenther Onkol. 2025 Mar;201(3):266-273. doi: 10.1007/s00066-024-02281-z. Epub 2024 Aug 30.
2
Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07).
BMC Cancer. 2024 Apr 11;24(1):449. doi: 10.1186/s12885-024-12170-4.
3
A focused review of statistical practices for relating radiation dose-volume exposure and toxicity.
Radiat Oncol. 2023 Mar 24;18(1):57. doi: 10.1186/s13014-023-02220-9.
4
Automated Contouring and Planning in Radiation Therapy: What Is 'Clinically Acceptable'?
Diagnostics (Basel). 2023 Feb 10;13(4):667. doi: 10.3390/diagnostics13040667.
5
Head and Neck Radiation Therapy Patterns of Practice Variability Identified as a Challenge to Real-World Big Data: Results From the Learning from Analysis of Multicentre Big Data Aggregation (LAMBDA) Consortium.
Adv Radiat Oncol. 2022 Feb 23;8(1):100925. doi: 10.1016/j.adro.2022.100925. eCollection 2023 Jan-Feb.
6
The Impact of Interactive MRI-Based Radiologist Review on Radiotherapy Target Volume Delineation in Head and Neck Cancer.
AJNR Am J Neuroradiol. 2023 Feb;44(2):192-198. doi: 10.3174/ajnr.A7773. Epub 2023 Jan 26.
7
Experience With Normal Breathhold Planning Scans for Radiosurgery of Moving Targets With Live Tracking.
Cureus. 2022 Oct 25;14(10):e30676. doi: 10.7759/cureus.30676. eCollection 2022 Oct.
8
External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors.
Clin Transl Radiat Oncol. 2022 Nov 4;38:57-61. doi: 10.1016/j.ctro.2022.10.012. eCollection 2023 Jan.
9
Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors.
J Natl Cancer Inst. 2022 Sep 9;114(9):1270-1278. doi: 10.1093/jnci/djac125.
10
Estimating the tolerance of brachial plexus to hypofractionated stereotactic body radiotherapy: a modelling-based approach from clinical experience.
Radiat Oncol. 2021 Jun 7;16(1):98. doi: 10.1186/s13014-021-01822-5.
本文引用的文献
1
Analysis of radiation pneumonitis risk using a generalized Lyman model.
Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):568-74. doi: 10.1016/j.ijrobp.2008.04.053.
2
A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data.
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):985-92. doi: 10.1016/j.ijrobp.2007.04.077. Epub 2007 Aug 6.
3
The atlas of complication incidence: a proposal for a new standard for reporting the results of radiotherapy protocols.
Semin Radiat Oncol. 2006 Oct;16(4):260-8. doi: 10.1016/j.semradonc.2006.04.009.
4
Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):754-61. doi: 10.1016/j.ijrobp.2006.06.002. Epub 2006 Sep 11.
5
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1075-86. doi: 10.1016/j.ijrobp.2006.01.051. Epub 2006 May 2.
6
Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters.
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):112-24. doi: 10.1016/j.ijrobp.2005.11.046.
7
Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
Radiother Oncol. 2006 Mar;78(3):270-5. doi: 10.1016/j.radonc.2006.02.017. Epub 2006 Mar 27.
8
Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1151-61. doi: 10.1016/j.ijrobp.2005.10.002. Epub 2006 Jan 18.
9
Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
Radiother Oncol. 2005 Nov;77(2):164-71. doi: 10.1016/j.radonc.2005.10.002. Epub 2005 Oct 26.
10
Statistical analysis of dose-volume and dose-wall histograms for rectal toxicity following 3D-CRT in prostate cancer.
Med Phys. 2005 Aug;32(8):2503-9. doi: 10.1118/1.1951427.
Zotero 插件